0.7806
price down icon0.41%   -0.0032
after-market Handel nachbörslich: .78 -0.0006 -0.08%
loading

Evogene Ltd Aktie (EVGN) Neueste Nachrichten

pulisher
11:32 AM

Movement Recap: Can Evogene Ltd disrupt its industry2026 Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn

11:32 AM
pulisher
11:08 AM

Portfolio Recap: Is Evogene Ltd a play on infrastructure spending2026 Bull vs Bear & AI Forecast for Swing Trade Picks - baoquankhu1.vn

11:08 AM
pulisher
03:15 AM

Evogene receives Nasdaq notification - MSN

03:15 AM
pulisher
12:15 PM

[EFFECT] Evogene Ltd. SEC Filing - Stock Titan

12:15 PM
pulisher
Apr 04, 2026

Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026
pulisher
Apr 03, 2026

Evogene receives Nasdaq delisting warning over share price By Investing.com - Investing.com Canada

Apr 03, 2026
pulisher
Apr 02, 2026

Evogene reports receipt of Nasdaq minimum bid price notification - marketscreener.com

Apr 02, 2026
pulisher
Apr 02, 2026

Evogene receives Nasdaq delisting warning over share price - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026 - TipRanks

Apr 02, 2026
pulisher
Apr 02, 2026

Evogene Gets Nasdaq Minimum Bid Price Notification - marketscreener.com

Apr 02, 2026
pulisher
Apr 02, 2026

Nasdaq warns Evogene (NASDAQ: EVGN) over $1.00 minimum bid rule - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Nasdaq gives Evogene until Sept. 28 to fix its sub-$1 stock price - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Evogene stock soars after licensing deal for cancer therapeutic - investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Evogene Ltd Stock: Pioneering AI-Driven Plant Genomics for Sustainable Agriculture Markets - AD HOC NEWS

Apr 02, 2026
pulisher
Apr 01, 2026

Casterra reports successful castor farming trials in Brazil By Investing.com - Investing.com South Africa

Apr 01, 2026
pulisher
Mar 31, 2026

Evogene Ltd. (EVGN) Stock Price, News, Quote & History - Yahoo Finance

Mar 31, 2026
pulisher
Mar 31, 2026

Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock - Finviz

Mar 31, 2026
pulisher
Mar 31, 2026

Casterra reports successful castor farming trials in Brazil - investing.com

Mar 31, 2026
pulisher
Mar 31, 2026

Evogene files for resale of 5.08M shares via warrant exercise - MSN

Mar 31, 2026
pulisher
Mar 31, 2026

Brazil field trials show castor oil can scale as a biofuel feedstock - Stock Titan

Mar 31, 2026
pulisher
Mar 30, 2026

EVGN SEC FilingsEvogene 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 30, 2026
pulisher
Mar 30, 2026

Chipmakers Recap: Will Evogene Ltd stock hit new highs in YEAREarnings Miss & Smart Allocation Stock Tips - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Market Recap: Is Evogene Ltd stock a hidden gemCEO Change & Precise Buy Zone Tips - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 26, 2026

Evogene (NASDAQ: EVGN) resale registration for 5.08M ordinary shares - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Armistice selling up to 2.45M Evogene shares (NASDAQ: EVGN) - Stock Titan

Mar 26, 2026
pulisher
Mar 25, 2026

Evogene Ltd Stock Faces Pressure Amid Biotech Sector Volatility and Pipeline Delays in 2026 - AD HOC NEWS

Mar 25, 2026
pulisher
Mar 23, 2026

Evogene Earnings Call: AI Ambition Meets Cash Reality - TipRanks

Mar 23, 2026
pulisher
Mar 22, 2026

If You Invested $1,000 in Evogene (EVGN) - Stock Titan

Mar 22, 2026
pulisher
Mar 22, 2026

Evogene appoints Dr. Olga Nissan as vice president of business development to drive AI-driven growth - MSN

Mar 22, 2026
pulisher
Mar 20, 2026

EVGN PE Ratio & Valuation, Is EVGN Overvalued - Intellectia AI

Mar 20, 2026
pulisher
Mar 18, 2026

Evogene (EVGN) director Leon Recanati details share and option holdings - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Evogene (EVGN) director Nir details multiple stock option grants in Form 3 - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Evogene (EVGN) director details stock option grants and vesting - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Evogene (EVGN) chief development officer reports 40,000-share stock option grant - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

[Form 3] Evogene Ltd. Initial Statement of Beneficial Ownership - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Evogene (EVGN) director Sarit Firon details long-dated stock option grants - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Evogene (EVGN) CFO details RSU and stock option holdings - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

Evogene (EVGN) CEO Haviv Ofer details multi-year stock option grants - Stock Titan

Mar 18, 2026
pulisher
Mar 15, 2026

Evogene Ltd Stock (ISIN: IL0010831684) Faces Biotech Volatility Amid AI-Driven Crop Innovation Push - AD HOC NEWS

Mar 15, 2026
pulisher
Mar 14, 2026

Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline By GuruFocus - Investing.com Canada

Mar 14, 2026
pulisher
Mar 13, 2026

Evogene (EVGN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Mar 13, 2026
pulisher
Mar 11, 2026

Evogene outlines ChemPass AI-driven strategy and anticipates new collaborations amid organizational realignment - MSN

Mar 11, 2026
pulisher
Mar 10, 2026

Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 - Sahm

Mar 10, 2026
pulisher
Mar 07, 2026

Evogene Ltd. (NASDAQ:EVGN) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 07, 2026
pulisher
Mar 06, 2026

Evogene Financial Results: Quarterly and Annual ReportNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Mar 06, 2026
pulisher
Mar 06, 2026

Evogene Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 06, 2026
pulisher
Mar 06, 2026

Evogene: Q4 Earnings Snapshot - theheraldreview.com

Mar 06, 2026
pulisher
Mar 06, 2026

Evogene earnings missed by $0.20, revenue topped estimates - Investing.com Australia

Mar 06, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):